Access the full text.
Sign up today, get DeepDyve free for 14 days.
(2014a)
Learn if a medical device has been cleared by FDA for marketing
J. Chambers, M. Chenoweth, M. Cangelosi, J. Pyo, Joshua Cohen, P. Neumann (2015)
Medicare is scrutinizing evidence more tightly for national coverage determinations.Health affairs, 34 2
A. Pollack (2011)
Medical Treatment, Out of Reach
FDA Approves First Non-Invasive DNA Screening Test for Colorectal Cancer
(2011)
American Medical Device Makers Look Overseas for Quicker
(2014c)
Premarket approval (PMA)
Cost to Develop and Win Marketing Approval for a New Drug Is $2.6 Billion
(2015)
Exact Sciences Shares Plunge, Questions Arise for Insurers, Doctors.
(2017)
FDA, CMS: Second Parallel Review Decision Ever for NGS Test.
P. Neumann, J. Chambers (2012)
Medicare's enduring struggle to define "reasonable and necessary" care.The New England journal of medicine, 367 19
(2010)
FDA Impact on US Medical Technology Innovation: A Survey of over 200 Medical Technology Companies
(2013)
Market Size and Innovation: Effects
Exact Sciences Announces Final National Coverage Determination for Cologuard®
Gregory Herr (2010)
Biodesign: the process of innovating medical technologies.Biomedical instrumentation & technology, 44 5
John Ridge, S. Statz (2015)
Exact Sciences’ experience with the FDA and CMS parallel review programExpert Review of Molecular Diagnostics, 15
M. Meadows (2002)
The FDA's drug review process: ensuring drugs are safe and effective.FDA consumer, 36 4
(2015)
Technology Diffusion and Productivity Growth
J. Chambers, Katherine May, P. Neumann (2013)
Medicare covers the majority of FDA-approved devices and Part B drugs, but restrictions and discrepancies remain.Health affairs, 32 6
(2015)
“ Technology Diffusion and Productivity Growth in Health Care . ”
(2014)
How the Failure of Medtronic’s Symplicity Device Spells Trouble for FDA.
(1983)
Regulation of Pharmaceuticals:Balancing
(n.d)
National coverage determinations (NCDs) alphabetical index
(2016)
FDA Looks to Bring Payers to the Table at Device Pre-Submission
(2015)
Parallel Review Evolves: FDA Expands from Pilot
(2011)
American Medical Device Makers Look Overseas for Quicker Approval.
N. Weixel (2013)
Parallel Review expands. But will it get more participants?
Nicholas Bagley (2013)
Bedside Bureaucrats: Why Medicare Reform Hasn't WorkedUniversity of Michigan Law School
(2015)
“ Parallel Review Evolves : FDA Expands from Pilot to Considering Private Payers . ” Device Talk ( blog )
Amy Finkelstein (2007)
The Aggregate Effects of Health Insurance: Evidence from the Introduction of MedicareQuarterly Journal of Economics, 122
(2010)
Parallel Review of Medical Products
(2011)
Stifling Medical Device Innovation
(2013)
Parallel Review Expands
(2011)
Reimbursement Strategies for New Technologies.
D. Acemoglu, D. Cutler, Amy Finkelstein, Joshua Linn (2006)
Did Medicare Induce Pharmaceutical Innovation?HM: Effects of Medicare on General Health Care System (Topic)
(2006)
“ Did Medicare Induce Pharmaceutical Innovation ? ” Working Paper 11949 . National Bureau of Economic Research
(1998)
Quality-and-Safety Assurance: How Voluntary Social Processes
D. Klein (1998)
Quality-and-Safety Assurance: How Voluntary Social Processes Remedy Their Own ShortcomingsThe Independent Review, 2
Margaret Blume-Kohout, N. Sood (2013)
Market Size and Innovation: Effects of Medicare Part D on Pharmaceutical Research and Development.Journal of public economics, 97
(2012)
Medicare’s Enduring Struggle
(2014)
d . “ The FDA ’ s Drug Review Process : Ensuring Drugs Are Safe and Effective . ” WebContent . November 6 , 2014
(2015)
Parallel Review Evolves: FDA Expands from Pilot to Considering Private Payers.
FDA Announces Approval, CMS Proposes Coverage of First Breakthrough-Designated Test to Detect Extensive Number of Cancer Biomarkers
(2015)
Medicare Coverage Determination Process
Bureau of National Affairs. Health Care Blog (blog)
B. Bloom, H. Grabowski, J. Vernon (1984)
The regulation of pharmaceuticals : balancing the benefits and risksJournal of Policy Analysis and Management, 3
(2016)
FDA Looks to Bring Payers to the Table at Device Pre-Submission Meetings.
The purpose of this paper is to analyze the Parallel Review program that offers simultaneous review of the Food and Drug Administration premarket approval submissions and the Centers for Medicare and Medicaid Services (CMS) national coverage determinations (NCDs) of medical devices.Design/methodology/approachThe paper analyzes the impact of Parallel Review on medical device innovation, focusing in particular on the causes for low popularity of the program among medical device manufacturers. Program outcomes are evaluated in the light of its intended goals.FindingsThe paper identifies four reasons for the program’s limited impact. First, few devices are eligible to participate. Second, most manufacturers prefer to seek Medicare reimbursement at the local level as less risky than the CMS NCDs. Third, participation in the Parallel Review might actually delay the marketing of the device. Fourth, the program does not address numerous obstacles that device sponsors currently encounter. While giving the appearance of support for the medical device innovation, the policy falls short on its intended goals.Originality/valueThis paper elucidates the challenges to internal reform and serves as a reminder to political economists and health care researchers that to make disruptive innovation possible, we must continue to illuminate the otherwise unseen cost of marketing delays and document the ability of emergent market mechanisms to protect consumer safety.
Journal of Enterpreneurship and Public Policy – Emerald Publishing
Published: Nov 18, 2019
Keywords: Pilot program for Parallel Review of medical products; Food and Drug Administration; Centers for Medicare and Medicaid Services; Medical devices; Premarket approval; National coverage determinations; Local coverage determinations; Innovation; H75; I18
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.